These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11194707)

  • 21. Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas.
    Ezzat S; Smyth HS; Ramyar L; Asa SL
    J Clin Endocrinol Metab; 1995 Mar; 80(3):878-84. PubMed ID: 7883846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.
    Kim K; Arai K; Sanno N; Osamura RY; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):759-68. PubMed ID: 11422110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.
    Padova H; Rubinfeld H; Hadani M; Cohen ZR; Nass D; Taylor JE; Culler MD; Shimon I
    Mol Cell Endocrinol; 2008 May; 286(1-2):214-8. PubMed ID: 18276067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follicle stimulating hormone-beta subunit gene is expressed in parallel with a transcription factor Ad4BP/SF-1 in human pituitary adenomas.
    Ikuyama S; Ohe K; Sakai Y; Nakagaki H; Fukushima T; Kato Y; Morohashi K; Takayanagi R; Nawata H
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):187-93. PubMed ID: 8881451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic correlates of giant pituitary adenomas.
    Chacko G; Chacko AG; Lombardero M; Mani S; Seshadri MS; Kovacs K; Scheithauer BW
    J Clin Neurosci; 2009 May; 16(5):660-5. PubMed ID: 19285407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
    Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD
    J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymosin fraction 5 inhibits the proliferation of the rat neuroendocrine MMQ pituitary adenoma and C6 glioma cell lines in vitro.
    Spangelo BL; Farrimond DD; Thapa M; Bulathsinghala CM; Bowman KL; Sareh A; Hughes FM; Goldstein AL; Badamchian M
    Endocrinology; 1998 Apr; 139(4):2155-62. PubMed ID: 9529005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry].
    Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F
    Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
    Alexander JM; Swearingen B; Tindall GT; Klibanski A
    J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies.
    Barlier A; Zamora AJ; Grino M; Gunz G; Pellegrini-Bouiller I; Morange-Ramos I; Figarella-Branger D; Dufour H; Jaquet P; Enjalbert A
    J Neuroendocrinol; 1999 Jul; 11(7):491-502. PubMed ID: 10444306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level.
    Pagotto U; Marsicano G; Fezza F; Theodoropoulou M; Grübler Y; Stalla J; Arzberger T; Milone A; Losa M; Di Marzo V; Lutz B; Stalla GK
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2687-96. PubMed ID: 11397872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas.
    Lastoria S; Colao A; Vergara E; Ferone D; Varrella P; Merola B; Lombardi G; Salvatore M
    Eur J Endocrinol; 1995 Jul; 133(1):38-47. PubMed ID: 7627336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human pituitary corticotroph adenomas in vitro: morphologic and functional responses to corticotropin-releasing hormone and cortisol.
    Horvath SE; Asa SL; Kovacs K; Adams LA; Singer W; Smyth HS
    Neuroendocrinology; 1990 Mar; 51(3):241-8. PubMed ID: 2157992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Gonadotropin and Adrenocorticotropic Hormone Secretion on Invasiveness of Clinically Nonfunctioning Pituitary Adenomas: A Cell Culture Study.
    Usui S; Hama S; Tominaga A; Kinoshita Y; Kurisu K
    World Neurosurg; 2016 Dec; 96():578-584.e1. PubMed ID: 27601155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of human pituitary adenomas determines the pattern of chromogranin/secretogranin messenger ribonucleic acid expression.
    Jin L; Chandler WF; Smart JB; England BG; Lloyd RV
    J Clin Endocrinol Metab; 1993 Mar; 76(3):728-35. PubMed ID: 7680355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
    Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK
    Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gonadotropin-releasing hormone regulates gonadotropin beta-subunit and chromogranin-B messenger ribonucleic acids in cultured chromogranin-A-positive pituitary adenomas.
    Song JY; Jin L; Chandler WF; England BG; Smart JB; Landefeld TD; Lloyd RV
    J Clin Endocrinol Metab; 1990 Sep; 71(3):622-30. PubMed ID: 2118538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
    Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
    Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activin effects on neoplastic proliferation of human pituitary tumors.
    Danila DC; Inder WJ; Zhang X; Alexander JM; Swearingen B; Hedley-Whyte ET; Klibanski A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1009-15. PubMed ID: 10720031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.